A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer

Clinical trial NCT00564928 · COMPLETED

Trial details

NCT number: NCT00564928
Sponsor: Infinity Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostatic Neoplasms Cancer of the Prostate

Start date: 2007-11-01
Primary completion: 2010-03-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.